{"title":"Anticipating artificial intelligence in mammography screening: views of Swedish breast radiologists.","authors":"Charlotte Högberg, Stefan Larsson, Kristina Lång","doi":"10.1136/bmjhci-2022-100712","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Artificial intelligence (AI) is increasingly tested and integrated into breast cancer screening. Still, there are unresolved issues regarding its possible ethical, social and legal impacts. Furthermore, the perspectives of different actors are lacking. This study investigates the views of breast radiologists on AI-supported mammography screening, with a focus on attitudes, perceived benefits and risks, accountability of AI use, and potential impact on the profession.</p><p><strong>Methods: </strong>We conducted an online survey of Swedish breast radiologists. As early adopter of breast cancer screening, and digital technologies, Sweden is a particularly interesting case to study. The survey had different themes, including: attitudes and responsibilities pertaining to AI, and AI's impact on the profession. Responses were analysed using descriptive statistics and correlation analyses. Free texts and comments were analysed using an inductive approach.</p><p><strong>Results: </strong>Overall, respondents (47/105, response rate 44.8%) were highly experienced in breast imaging and had a mixed knowledge of AI. A majority (n=38, 80.8%) were positive/somewhat positive towards integrating AI in mammography screening. Still, many considered there to be potential risks to a high/somewhat high degree (n=16, 34.1%) or were uncertain (n=16, 34.0%). Several important uncertainties were identified, such as defining liable actor(s) when AI is integrated into medical decision-making.</p><p><strong>Conclusions: </strong>Swedish breast radiologists are largely positive towards integrating AI in mammography screening, but there are significant uncertainties that need to be addressed, especially regarding risks and responsibilities. The results stress the importance of understanding actor-specific and context-specific challenges to responsible implementation of AI in healthcare.</p>","PeriodicalId":9050,"journal":{"name":"BMJ Health & Care Informatics","volume":"30 1","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230899/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Health & Care Informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjhci-2022-100712","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Artificial intelligence (AI) is increasingly tested and integrated into breast cancer screening. Still, there are unresolved issues regarding its possible ethical, social and legal impacts. Furthermore, the perspectives of different actors are lacking. This study investigates the views of breast radiologists on AI-supported mammography screening, with a focus on attitudes, perceived benefits and risks, accountability of AI use, and potential impact on the profession.
Methods: We conducted an online survey of Swedish breast radiologists. As early adopter of breast cancer screening, and digital technologies, Sweden is a particularly interesting case to study. The survey had different themes, including: attitudes and responsibilities pertaining to AI, and AI's impact on the profession. Responses were analysed using descriptive statistics and correlation analyses. Free texts and comments were analysed using an inductive approach.
Results: Overall, respondents (47/105, response rate 44.8%) were highly experienced in breast imaging and had a mixed knowledge of AI. A majority (n=38, 80.8%) were positive/somewhat positive towards integrating AI in mammography screening. Still, many considered there to be potential risks to a high/somewhat high degree (n=16, 34.1%) or were uncertain (n=16, 34.0%). Several important uncertainties were identified, such as defining liable actor(s) when AI is integrated into medical decision-making.
Conclusions: Swedish breast radiologists are largely positive towards integrating AI in mammography screening, but there are significant uncertainties that need to be addressed, especially regarding risks and responsibilities. The results stress the importance of understanding actor-specific and context-specific challenges to responsible implementation of AI in healthcare.
目的:人工智能(AI)越来越多地应用于乳腺癌筛查。然而,有关其可能产生的伦理、社会和法律影响的问题仍未得到解决。此外,还缺乏不同参与者的观点。本研究调查了乳腺放射科医生对人工智能支持的乳腺X光筛查的看法,重点是态度、感知到的益处和风险、人工智能使用的责任以及对行业的潜在影响:我们对瑞典乳腺放射科医生进行了在线调查。作为乳腺癌筛查和数字技术的早期采用者,瑞典是一个特别值得研究的案例。调查有不同的主题,包括:对人工智能的态度和责任,以及人工智能对该行业的影响。我们使用描述性统计和相关性分析对答复进行了分析。自由文本和评论采用归纳法进行分析:总体而言,受访者(47/105,回复率 44.8%)在乳腺成像方面经验丰富,对人工智能的了解程度参差不齐。大多数受访者(38 人,占 80.8%)对将人工智能纳入乳腺 X 光筛查持积极或略为积极的态度。但也有很多人认为潜在风险很高(16 人,34.1%)或不确定(16 人,34.0%)。研究还发现了一些重要的不确定因素,如在将人工智能纳入医疗决策时如何界定责任主体:结论:瑞典乳腺放射医师对将人工智能纳入乳腺 X 射线筛查持积极态度,但仍有许多不确定因素需要解决,尤其是在风险和责任方面。研究结果强调了了解特定行为者和特定环境对负责任地将人工智能应用于医疗保健的挑战的重要性。